Imagine a faster, inexpensive method for breast cancer screening. That’s some of the promise behind a new innovation from doctoral student, Sevan Goenezen, who has discovered a way to use ultrasound and advanced algorithms to differentiate between benign and malignant tumors.
[[{"type":"media","view_mode":"media_crop","fid":"1735","attributes":{"alt":"","class":"media-image","id":"media_crop_7567161365917","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"201","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","title":" ","typeof":"foaf:Image"}}]]Imagine a fast, inexpensive method for breast cancer screening. That’s some of the promise behind a new innovation from a doctoral student who has discovered a way to use ultrasound and advanced algorithms to differentiate between benign and malignant tumors.
Sevan Goenezen, a student at the department of mechanical, aerospace, and nuclear engineering at Rensselaer Polytechnic Institute, researched nonlinear elasticity imaging for breast cancer diagnosis. Here Geonezen and his faculty advisor, Assad Oberai, discuss this innovation and what it could mean for breast cancer diagnosis, as well as diagnosis of other diseases.
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
New AI-Powered Ultrasound Devices May Enhance Efficiency in Women's Imaging
April 19th 2024One of the features on the new Voluson Signature 20 and 18 ultrasound devices reportedly uses automated AI tools to facilitate a 40 percent reduction in the time it takes to perform second trimester exams.
New Research Examines Socioeconomic Factors with Mammography No-Shows
April 10th 2024Patients with Medicaid or means-tested insurance were over 27 percent more likely to miss mammography appointments, and only 65 percent of women with three of more adverse social determinants of health had a mammography exam in a two-year period covering 2020 and 2021, according to new research and a report from the CDC.
Mammography-Based AI Abnormality Scoring May Improve Prediction of Invasive Upgrade of DCIS
April 9th 2024Emerging research suggests that an artificial intelligence (AI) score of 75 or greater for mammography abnormalities more than doubles the likelihood of invasive upgrade of ductal carcinoma in situ (DCIS) diagnosed with percutaneous biopsy.